查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2016756

眼壓計市場規模、佔有率、趨勢和預測：按類型、技術、便攜性、最終用戶和地區分類，2026-2034年

Tonometer Market Size, Share, Trends and Forecast by Type, Technology, Portability, End User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

2025年全球眼壓計市場規模達3.918億美元。預計2026年至2034年將以4.3%的複合年成長率成長，到2034年達到5.798億美元。全球青光眼盛行率上升（目前全球超過8,000萬人受其影響，預計到2040年將超過1.1億人）、人口老化以及人工智慧整合攜帶式設備的開發是推動市場需求成長的主要因素。間接式眼壓計佔市場主導地位，市佔率高達64.6%，而壓平式眼壓計則佔主導地位，市佔率高達51.4%。北美地區佔最大的區域市場佔有率，達到39.6%，這得益於其完善的保險報銷機制和廣泛的眼科檢查項目。

市場概覽

預計從 2020 年到 2034 年，眼壓計市場將持續成長，到 2025 年達到 3.918 億美元，並朝著 5.798 億美元邁進，這反映了眼壓計在臨床實踐中的持續應用以及攜帶式設備的普及。

關鍵細分市場的複合年成長率約為：家庭終端用戶 8.4%，攜帶式設備 7.2%，反映出 2034 年，眼壓 (IOP) 監測將向分散式、以患者為中心的方向發展。

執行摘要

受臨床需求和設備創新推動，全球眼壓計市場正穩定擴張。青光眼仍然是全球導致不可逆性失明的主要原因之一，估計有8,000萬人受其影響。定期測量眼壓是主要的診斷手段，因此眼壓計是眼科診療不可或缺的工具。

預計到2025年，間接式眼壓計將佔眼壓計市場（按類型分類）的64.6%，這主要得益於其無需麻醉以及非接觸式氣流測量方法降低了交叉感染的風險。作為臨床黃金標準，壓平式眼壓計將佔51.4%的市場。回彈式眼壓計的成長速度最快，年複合成長率約為5.8%，主要得益於iCare手持式平台在小兒科和居家醫療領域的廣泛應用。

預計到2025年，北美將保持其39.6%的市場佔有率領先地位，這得益於一系列FDA已通過核准的醫療器材、完善的私人保險覆蓋範圍以及高密度的眼科醫生。亞太地區成長最快，市佔率達22.3%，這主要得益於中國、印度和日本不斷擴大的眼科醫療基礎設施。

關鍵市場洞察

基於以上數據的主要分析觀察：

  • 到2025年，間接式眼壓計將成為主流，佔64.6%的市佔率。這是因為其非接觸式設計無需麻醉，從而降低了繁忙臨床環境中操作的風險。 NIDEK的非接觸式眼壓計（NT-1/1e，2023年4月上市）減少了對操作者的依賴，並提高了臨床效率。
  • 壓平式眼壓計佔所有測量量的51.4%，並繼續保持主導地位。戈爾德曼壓平式眼壓計（GAT）是所有其他檢測法檢驗的基準。
  • 北美地區39.6%的市佔率反映了美國醫療保險和醫療補助服務中心（CMS）為高風險參保人員提供青光眼篩檢覆蓋。美國約有18,000名眼科醫生，這為裂隙燈和手持式眼壓計的普及應用奠定了堅實的基礎。

全球眼壓計市場概覽

眼壓計是醫療設備，眼內壓是指眼球內部液體的壓力。眼內壓升高是青光眼的主要可控危險因素，而青光眼是全球不可逆性失明的主要原因之一。眼壓計包括：臨床實踐中常用的與裂隙燈配合使用的戈爾德曼眼壓計（金標準）；手持式可攜式回彈眼壓計；以及非接觸式氣動眼壓計。

應用範圍涵蓋醫院眼科病房和門診、行動篩檢點、遠端醫療平台以及新興的家庭監測應用場景。絕大多數參與者（88%）能夠獨立使用眼壓計。大多數人（94%）對使用家用眼壓計充滿信心，並且通常在開始使用三天內就能熟練掌握。

市場動態

市場促進因素

  • 全球青光眼盛行率正在迅速上升：預計到 2040 年，全球青光眼患者人數將從 8,000 萬增加到 1.1 億，而開發中國家未確診的病例數量預計會更多。
  • 年齡成長與定期眼壓檢查：預計到2050年，全球60歲以上人口將達到21億人。老齡化是眼壓升高和原發性開放性青光眼的最強獨立危險因子。
  • 在印度國家防盲計畫、中國「健康中國2030」中的「視力保健目標」以及世衛組織「視覺2020」後續計畫的推動下，新興市場眼科醫療基礎設施不斷擴張，促使各國政府為地方眼科醫療機構購買眼壓計。

市場限制因素

  • 低收入和中等收入國家 (LMIC)高成本且報銷障礙：撒哈拉以南非洲、南亞和東南亞部分地區的報銷機制不完善，導致採購僅限於捐助者資助的項目，從而限制了在世界上青光眼負擔最重的地區進行市場滲透。
  • 開發中國家患者認知不足：在非洲許多地區，只有大約五分之一的青光眼患者知道自己患有此病，超過50%的患者在就醫時一隻眼睛已經失明。對該疾病認知度低導致對眼壓篩檢服務的需求減少，而這本應有助於在基層醫療機構購買眼壓計。

市場機遇

  • 可攜式穿戴式眼壓監測儀，適用於居家照護：家庭眼壓測量市場是成長最快的市場之一。 iCare HOME2 於 2022 年獲得 FDA核准，使青光眼患者能夠在家中自行測量眼壓，無需他人協助。
  • AI預測分析用於青光眼風險分層：透過將基於縱向眼壓資料集訓練的機器學習模型與從OCT獲得的視神經乳頭影像結合，可以在青光眼發病前3至5年預測由青光眼引起的視野缺損的進展。
  • 亞太地區政府視力篩檢計畫：印度的「Ayushman Bharat」健康計畫自2022年4月起涵蓋青光眼篩檢。這些政策支持的機構採購計畫將在2028年之前創造可預測的、對眼壓計的大量需求。

市場挑戰

  • 校準、維護和品質保證成本：在資源受限的環境中，缺乏校準設備會導致測量結果出現逐漸的偏差，而臨床醫生可能無法察覺，這給設備維護程序的操作人員帶來了挑戰，既關係到患者安全，也關係到監管合規性。
  • 來自整合多功能診斷平台的競爭：將 OCT、角膜地圖儀、角膜厚度測量和眼內壓測量整合到單一設備中的眼科診斷平台正被三級醫療機構採用。

新的市場趨勢

1. 人工智慧驅動的診斷整合重新定義了眼內壓測量。

2024年5月，拓普康醫療（Topcon Healthcare）和微軟宣布合作，在Azure雲端平台上開發一款基於人工智慧的「眼部健康護理」解決方案。此人工智慧演算法將眼內壓數據和視網膜影像結合起來進行分析，以檢測高血壓、糖尿病和神經系統疾病等全身性疾病。

2. 回彈式眼壓計正在被引入居家醫療和基層醫療。

Reichardt公司的「Tono-Vera」眼壓計於2024年5月在美國上市，它採用取得專利的ActiView定位系統和藍牙連接功能，可即時傳輸眼內壓（IOP）數據，提供先進的回彈式眼壓計測量體驗。由於無需麻醉和一次性探頭，家用回彈式眼壓計測量在臨床上實用，在商業性也具有可行性。

3. 用於自動化常規篩檢的非接觸式眼壓計

NIDEK 的 NT-1/1e 於 2023 年 4 月發布，它無需測量角膜厚度，即可自動測量眼壓，並具備語音指導和患者安全功能，從而簡化了工作流程。此非接觸式平台降低了操作人員的技能要求，使其能夠應用於常規篩檢，並可推廣至眼科專科以外的斜視矯正培訓和基層醫療機構。

4. 與電子病歷和遠端醫療平台整合

支援藍牙和Wi-Fi功能的眼壓計正擴大與電子病歷系統整合。在常規檢查中收集的眼壓數據會自動輸入到青光眼監測模板中，從而支持時間趨勢分析，並在眼壓超過個別目標閾值時發出臨床決策警報。

5. 穿戴式連續眼內壓監測的研究正在取得進展。

利用嵌入隱形眼鏡的感測器進行連續眼壓 (IOP) 監測，可以捕捉到單次診所測量無法記錄的 24 小時眼壓波動模式。預計市售穿戴式 SMP 監測儀將在 2027 年至 2029 年間率先進入專業市場，並吸引早期採用者，從而將眼壓測量市場拓展到連續監測這一新領域。

產業價值鏈分析

眼壓計的價值鏈涵蓋六個階段。設備製造和監管合規階段的固定成本最高，而分銷和臨床服務則創造了最高的經常性商機。

分銷部門透過與醫院集團簽訂獨家分銷代理協議，為醫院集團聯合採購產品，從而確保了約 18-22% 的毛利率。 iCare 的直接面向患者的家庭眼壓監測模式繞過了傳統的醫生處方自測套裝通路，這種升級的 DTC 管道提高了利潤率，現有 OEM 製造商也開始效仿。

眼壓計產業的技術趨勢

解釋技術：臨床實務中的黃金標準

Goldmann眼壓測定測量的是壓平標準3.06 mm角膜區域所需的力，它仍然是校準所有其他檢測法的公認標準。目前的數位化眼壓計系統採用電子力感測器，消除了對壓平終點的主觀判斷，並確保了臨床檢驗研究中結果的可重複性。

回彈式眼壓測量：使患者能夠進行自我監測。

回彈式眼壓測定方法是將磁性探頭發射到角膜表面並測量其減速情況；此方法無需麻醉或螢光素。獲得FDA核准的iCare HOME2平台可讓患者在家中自行測量眼壓，並將結果與使用Goldmann方法獲得的參考值進行比較。

人工智慧與互聯互通：下一代眼內壓測量

透過將機器學習演算法應用於縱向眼壓 (IOP) 資料集，現在可以對青光眼進展進行預測建模。拓普康與微軟 Azure 的合作展示了該技術的商業性部署。這款雲端原生眼壓測量平台能夠產生持續的縱向眼壓曲線，並將持續成為市場上最有價值的軟體層，直到 2034 年。

市場區隔分析

按類型

2025年，間接式眼壓計、非接觸式氣流眼壓計和回彈式眼壓計（無需接觸角膜即可測量眼壓）將佔64.6%的市場佔有率。這些設備無需麻醉，降低感染風險，並可快速測量眼壓，進而提高眼科檢查的患者處理效率。 NIDEK NT-1/1e 和 Topcon CT-1P 代表了高階非接觸式眼壓計市場，它們提供自動化測量功能，並針對測量困難的患者群體配備了安全特性。

直接式眼壓計，例如Goldmann壓平式眼壓計、Tonopen眼壓計和iCare手持式回彈式眼壓計，預計到2025年將佔據35.4%的市場佔有率。儘管其總體佔有率相對較低，但該細分市場的平均售價最高。在三級醫療機構中，直接式眼壓計至關重要，因為在這些機構中，青光眼診斷和法醫學記錄均依法要求進行參考眼壓測量。

透過技術

壓平式眼壓計仍佔主導地位，市佔率高達51.4%。 Goldmann壓平法仍然是所有臨床設備檢驗研究中必不可少的比較方法，在評估新型眼壓計技術的眼科中心，繼續採用該方法幾乎是強制性的。

回彈式眼壓計是成長最快的技術，預計到2025年將佔26.3%。其非接觸式和無需麻醉的使用者體驗正在推動其在三個接觸式測量方法不切實際的領域中得到應用：兒童眼科、獸醫實踐和家庭患者監測。點壓式眼壓測定，例如Siotz眼壓計（佔14.7%），適用於資源有限的環境，在這些環境中，低成本設備比測量精度更為重要。 「其他」類別（佔7.6%）包括眼部反應分析儀（ORA）、動態輪廓眼壓測定（DCT）以及正在進行臨床檢驗的新興穿戴式式眼壓感測器技術。

區域市場趨勢

預計到2025年，北美將佔據39.6%的市場佔有率，這主要得益於結構性醫療保健需求和強大的商業生態系統的綜效。美國醫療保險和醫療補助服務中心（CMS）為高風險的聯邦醫療保險受益人提供年度青光眼篩檢，這些受益人包括糖尿病患者、有青光眼家族病史者、50歲及以上的非裔美國人以及65歲及以上的西班牙裔美國人，這直接推動了眼壓計在診所層面的普及。

亞太地區佔全球青光眼需求量的22.3%（2025年預測），由於三個因素的共同作用，該地區正經歷最快的成長。日本人口老化（65歲以上人口占29.4%）導致亞太地區人均青光眼診斷需求最高。歐洲（佔23.1%）受益於歐洲青光眼學會制定的標準化臨床指南，該指南規定在所有臨床青光眼診斷中，Goldmann壓平式眼壓計是眼壓測定，並且歐盟各地的眼科診所都穩定地採用裂隙燈壓平式眼壓計。

競爭格局

全球眼壓計市場正經歷適度整合。市場呈現兩極化，一邊是高階臨床平台，另一邊是價格親民、攜帶式創新的產品。

從市場佔有率和策略投資的角度來看，2025 年在全球市場的競爭定位。

本報告解答的主要問題

1. 2025年，全球眼壓計市場規模將達到多少？

2. 到 2034 年，眼壓計市場的發展趨勢預測如何？

3. 哪種類型的眼壓計在全球市場中佔據主導地位？

4. 哪一種技術在眼壓計市場佔據主導地位？

5. 哪個地區在眼壓計市場中處於領先地位？

6. 眼壓計市場的主要成長要素為何？

7. 眼壓計市場的主要企業有哪些？

8. 成長最快的眼壓計技術是什麼？

9. 人工智慧如何改變眼壓計市場？

10. Reichert Tono-Vera 的上市情況如何？

11. 家用眼壓計市場是如何成長的？

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球眼壓計市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依類型

  • 直接的
  • 間接

第7章 市場區隔：依技術分類

  • 眼壓測定
  • 眼壓測定
  • 反彈式眼內壓測量
  • 其他

第8章 市場區隔：依便攜性分類

  • 桌面
  • 手持式

第9章 市場區隔：依最終用戶分類

  • 醫院
  • 眼科中心

第10章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第11章 SWOT 分析

第12章：價值鏈分析

第13章：波特五力分析

第14章：價格分析

第15章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Haag-Streit Group
    • Topcon Corporation
    • Reichert Technologies（Ametek）
    • NIDEK CO. LTD.
    • iCare Finland Oy
    • Keeler
    • Tomey Corporation
    • Marco
Product Code: SR112026A4759

The global tonometer market size reached USD 391.8 Million in 2025. It is projected to reach USD 579.8 Million by 2034, at a CAGR of 4.3% during 2026-2034. Rising global glaucoma prevalence, affecting over 80 million people worldwide and is expected to exceed 110 million by 2040, aging demographics, and AI-integrated portable devices are the core demand drivers. Indirect tonometers lead at 64.6% share, while applanation technology dominates at 51.4%. North America holds the largest regional share at 39.6%, underpinned by strong reimbursement frameworks and widespread ophthalmic screening programs.

MARKET SNAPSHOT

The tonometer market growth from 2020 through 2034, expanded to USD 391.8 Million in 2025, and the forecast trajectory toward USD 579.8 Million reflects sustained clinical adoption and portable device expansion.

The CAGR across key segments with home-use end-user leads at ~8.4% and portable devices at ~7.2%, reflecting the shift toward decentralized, patient-convenient intraocular pressure (IOP) monitoring through 2034.

EXECUTIVE SUMMARY

The global tonometer market is expanding steadily, driven by a convergence of clinical necessity and device innovation. Glaucoma remains the leading cause of irreversible blindness globally with over 80 million individuals are estimated to be living with glaucoma. Regular IOP measurement is the primary diagnostic tool, making tonometers indispensable in ophthalmic practice.

Indirect tonometers command 64.6% of the 2025 type segment, as non-contact air-puff designs eliminate anesthesia requirements and reduce cross-contamination risk. Applanation tonometry, the clinical gold standard, holds 51.4% technology share. Rebound tonometry is the fastest-growing at ~5.8% CAGR, driven by iCare's handheld platforms gaining wide adoption in pediatric and home-care settings.

North America leads at 39.6% in 2025, supported by FDA-approved device pipelines, strong private insurance reimbursement, and high ophthalmologist density. Asia-Pacific at 22.3% is the fastest-growing region, fueled by expanding ophthalmic infrastructure in China, India, and Japan.

KEY MARKET INSIGHTS

KEY ANALYTICAL OBSERVATIONS ALIGNED WITH THE ABOVE DATA:

  • Indirect tonometers, with 64.6% in 2025, dominate because non-contact designs remove anesthesia requirements, lowering procedural risk in high-throughput clinic settings. Non-contact tonometer from NIDEK (NT-1/1e, April 2023) reduces operator dependency and improve throughput.
  • Applanation tonometry at 51.4% retains its dominance as the ISO-recognized clinical standard. Goldmann Applanation Tonometry (GAT) provides the reference against which all other methods are validated.
  • North America's 39.6% leadership reflects the US Centers for Medicare & Medicaid Services (CMS) coverage of glaucoma screening for high-risk beneficiaries. Approximately 18,000 ophthalmologists practice in the US, creating a dense deployment base for slit-lamp-mounted and handheld tonometers.

GLOBAL TONOMETER MARKET OVERVIEW

A tonometer is a medical device that measures intraocular pressure (IOP), the fluid pressure inside the eye. Elevated IOP is the primary modifiable risk factor for glaucoma, the world's leading cause of irreversible blindness. Devices span clinical slit-lamp-mounted gold-standard Goldmann tonometers, handheld portable rebound devices, and non-contact air-puff instruments.

Applications extend from hospital ophthalmology wards and ophthalmic clinics to mobile screening camps, telemedicine platforms, and emerging home-monitoring use cases. The majority of participants (88%) were able to use the tonometer independently. Most felt confident in using the home tonometer (94%), with proficiency generally reached by the third day of use.

MARKET DYNAMICS

MARKET DRIVERS

  • Surging Global Glaucoma Prevalence: The global glaucoma cases to rise from 80 million to 110 million by 2040, with more cases undiagnosed in developing economies.
  • Aging Population and Routine IOP Screening: The global population aged 60+ is expected to reach 2.1 billion by 2050. Age is the strongest independent risk factor for elevated IOP and primary open-angle glaucoma.
  • Expanding Ophthalmic Infrastructure in Emerging Markets: The National Blindness Control Program& Visual Impairment in India, China's Healthy China 2030 vision care targets, and WHO's VISION 2020 successors are collectively driving government procurement of tonometers for district-level eye care facilities.

MARKET RESTRAINTS

  • High Device Cost and Reimbursement Barriers in LMICs: In Sub-Saharan Africa, South Asia, and parts of Southeast Asia, inadequate reimbursement structures limit procurement to donor-funded programmes, constraining market penetration in the world's highest-glaucoma-burden geographies.
  • Limited Patient Awareness in Developing-Nation Populations: In much of Africa, only about 1 in 20 individuals with glaucoma are aware of their condition, and more than 50% are already blind in one eye when they seek help. Low disease awareness reduces the demand pull for IOP screening services that would otherwise drive tonometer procurement at primary care level.

MARKET OPPORTUNITIES

  • Portable and Wearable IOP Monitoring for Home Care: The home tonometry market represents the fastest-expanding opportunity. iCare HOME2, cleared by the FDA in 2022, enables patients with glaucoma to measure their own IOP at home without assistance.
  • AI Predictive Analytics for Glaucoma Risk Stratification: Machine learning models trained on longitudinal IOP datasets, combined with OCT disc imaging, can predict glaucomatous visual field progression 3-5 years ahead of onset.
  • Government Vision Screening Programmes in Asia-Pacific: India's Ayushman Bharat health programme covers glaucoma screening in April 2022. These policy-backed institutional procurement programmes create predictable, volume-significant tonometer demand through 2028.

MARKET CHALLENGES

  • Calibration Maintenance and Quality Assurance Costs: In resource-constrained settings, calibration equipment unavailability leads to progressive measurement drift that clinicians may not detect, creating both patient safety and regulatory compliance challenges for device maintenance programme operators.
  • Competition from Integrated Multi-Function Diagnostic Platforms: Ophthalmic diagnostic platforms integrating OCT, corneal topography, pachymetry, and tonometry in a single device are gaining adoption in tertiary centers.

EMERGING MARKET TRENDS

1. AI-POWERED DIAGNOSTIC INTEGRATION REDEFINING TONOMETRY

In May 2024, Topcon Healthcare and Microsoft announced a collaboration to develop AI-driven 'Healthcare from the Eye' solutions on Azure cloud. AI algorithms analyze IOP data alongside retinal imaging to detect systemic conditions including hypertension, diabetes, and neurological disorders.

2. REBOUND TONOMETERS ENTERING HOME AND PRIMARY CARE

Reichert's Tono-Vera's US launch in May 2024 features the patented ActiView positioning system proving Refined Rebound Tonometer Experience with Bluetooth connectivity for real-time IOP data transmission. Eliminating anesthesia and disposable probes makes home rebound tonometry both clinically practical and commercially viable.

3. NON-CONTACT TONOMETERS AUTOMATING ROUTINE SCREENING

NIDEK's NT-1/1e launched in April 2023 eliminates pachymetry to reduce workflow complexity, offering automated IOP measurement with voice guidance and patient safety features. Non-contact platforms are reducing the operator skill threshold for routine screening, enabling deployment to optometry and primary care settings outside specialist ophthalmology.

4. EHR AND TELEMEDICINE PLATFORM INTEGRATION

Bluetooth and Wi-Fi-enabled tonometers are increasingly integrated with EHR systems. IOP data captured during routine consultations auto-populates glaucoma monitoring templates, supporting longitudinal trend analysis and clinical decision alerts when IOP exceeds individualized target thresholds.

5. WEARABLE CONTINUOUS IOP MONITORING RESEARCH ADVANCING

Continuous IOP monitoring using contact lens-embedded sensors measures 24-hour IOP fluctuation patterns that single clinic-based measurements cannot capture. Commercial wearable continuous IOP monitors are projected to reach early-adopter specialist markets by 2027-2029, expanding the addressable tonometry market into a new continuous-monitoring category.

INDUSTRY VALUE CHAIN ANALYSIS

The tonometer value chain spans six stages. Device manufacturers and regulatory compliance represent the highest fixed cost stages, while distribution and clinical service create the highest recurring revenue opportunities.

Distribution captures an estimated 18-22% gross margin through exclusive dealer arrangements in hospital group purchasing. iCare's direct-to-patient home tonometry model, bypassing traditional distribution through physician-prescribed self-monitoring kits, represents a margin-enhancing DTC channel evolution that established OEMs are beginning to replicate.

TECHNOLOGY LANDSCAPE IN THE TONOMETER INDUSTRY

APPLANATION TECHNOLOGY: THE CLINICAL GOLD STANDARD

Goldmann Applanation Tonometry, measuring the force required to flatten a standard 3.06 mm corneal area, remains the reference standard against which all other modalities are calibrated. Digital applanation systems now embed electronic force transducers that eliminate subjective mire endpoint interpretation, achieving repeatability in clinical validation studies.

REBOUND TONOMETRY: ENABLING PATIENT SELF-MONITORING

Rebound tonometry, firing a magnetized probe at the corneal surface and measuring deceleration, requires no anesthesia or fluorescein. iCare's HOME2 platform, cleared by the FDA, allows patients to self-measure IOP at home with results of the Goldmann reference.

AI AND CONNECTIVITY: NEXT-GENERATION TONOMETRY

Machine learning algorithms applied to longitudinal IOP datasets are enabling predictive glaucoma progression modelling. Topcon's partnership with Microsoft Azure demonstrates the commercial trajectory. Cloud-native tonometry platforms generating persistent longitudinal IOP profiles represent the market's highest-value software layer through 2034.

MARKET SEGMENTATION ANALYSIS

BY TYPE

Indirect tonometers, non-contact air-puff and rebound designs that measure IOP without touching the cornea, command 64.6% in 2025. They eliminate anesthesia, reduce infection risk, and are faster to administer, enabling higher patient throughput in ophthalmic screening settings. NIDEK NT-1/1e and Topcon CT-1P represent the premium non-contact segment offering automated measurement with safety features for challenging patient groups.

Direct tonometers, including Goldmann applanation, Tonopen, and iCare handheld rebound devices, hold 35.4% in 2025. Despite a lower overall share, this segment commands the highest average selling prices. Direct tonometers are irreplaceable in tertiary clinical settings where reference-standard IOP measurements are legally and clinically mandated for glaucoma diagnosis and medico-legal documentation.

BY TECHNOLOGY

Applanation tonometry at 51.4% retains its dominant position. Goldmann applanation remains the required comparison method in all clinical device validation studies, effectively mandating its continued presence in any ophthalmic center where new tonometer technologies are evaluated.

Rebound tonometry at 26.3% (2025) is the fastest-growing technology. The no-touch, no-anesthesia user experience drives adoption in pediatric ophthalmology, veterinary practice, and patient home-monitoring, three segments where contact techniques are impractical. Indentation tonometry (14.7%), represented by Schiotz instruments, serves resource-limited settings where low device cost outweighs measurement precision limitations. The others category (7.6%) includes ocular response analyzer (ORA), dynamic contour tonometry (DCT), and emerging wearable IOP sensor technologies in clinical validation.

REGIONAL MARKET INSIGHTS

North America commands 39.6% in 2025 through a combination of structural healthcare demand and strong commercial ecosystems. The US CMS covers annual glaucoma screening for high-risk Medicare beneficiaries, those with diabetes mellitus, a family history of glaucoma, African American heritage over age 50, or Hispanic heritage over age 65, directly driving clinic-level tonometer procurement.

Asia-Pacific at 22.3% (2025) is growing at the fastest rate, driven by three concurrent forces. Japan's aging population, 29.4% of citizens are aged 65+, generates the highest per-capita glaucoma diagnostic demand in the Asia-Pacific region. Europe (23.1%) benefits from the European Glaucoma Society's standardized care guidelines mandating Goldmann applanation as the preferred IOP measurement modality for all clinical glaucoma diagnoses, sustaining consistent slit-lamp-mounted applanation tonometer procurement across the EU's ophthalmology practices.

COMPETITIVE LANDSCAPE

The global tonometer market is moderately consolidated. The market bifurcates between premium clinical platforms and accessible portable innovators.

The competitive positioning across global market presence and strategic investment dimensions for 2025.

KEY QUESTIONS ANSWERED IN THIS REPORT

1. What is the global tonometer market size in 2025?

2. What is the tonometer market forecast through 2034?

3. Which type leads the global tonometer market?

4. Which technology dominates the tonometer market?

5. Which region leads the tonometer market?

6. What are the key drivers of the tonometer market?

7. Who are the key companies in the tonometer market?

8. What is the fastest-growing tonometer technology?

9. How is AI changing the tonometer market?

10. What was the Reichert Tono-Vera launch?

11. How is the home-use tonometer segment growing?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Tonometer Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Direct
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Indirect
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Applanation Tonometry
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Indentation Tonometry
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Rebound Tonometry
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Portability

  • 8.1 Desktop
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Handheld
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Ophthalmic Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Haag-Streit Group
      • 15.3.1.1 Business Overview
      • 15.3.1.2 Products Offered
      • 15.3.1.3 Business Strategies
      • 15.3.1.4 SWOT Analysis
      • 15.3.1.5 Major News and Events
    • 15.3.2 Topcon Corporation
      • 15.3.2.1 Business Overview
      • 15.3.2.2 Products Offered
      • 15.3.2.3 Business Strategies
      • 15.3.2.4 SWOT Analysis
      • 15.3.2.5 Major News and Events
    • 15.3.3 Reichert Technologies (Ametek)
      • 15.3.3.1 Business Overview
      • 15.3.3.2 Products Offered
      • 15.3.3.3 Business Strategies
      • 15.3.3.4 SWOT Analysis
      • 15.3.3.5 Major News and Events
    • 15.3.4 NIDEK CO. LTD.
      • 15.3.4.1 Business Overview
      • 15.3.4.2 Products Offered
      • 15.3.4.3 Business Strategies
      • 15.3.4.4 SWOT Analysis
      • 15.3.4.5 Major News and Events
    • 15.3.5 iCare Finland Oy
      • 15.3.5.1 Business Overview
      • 15.3.5.2 Products Offered
      • 15.3.5.3 Business Strategies
      • 15.3.5.4 SWOT Analysis
      • 15.3.5.5 Major News and Events
    • 15.3.6 Keeler
      • 15.3.6.1 Business Overview
      • 15.3.6.2 Products Offered
      • 15.3.6.3 Business Strategies
      • 15.3.6.4 SWOT Analysis
      • 15.3.6.5 Major News and Events
    • 15.3.7 Tomey Corporation
      • 15.3.7.1 Business Overview
      • 15.3.7.2 Products Offered
      • 15.3.7.3 Business Strategies
      • 15.3.7.4 SWOT Analysis
      • 15.3.7.5 Major News and Events
    • 15.3.8 Marco
      • 15.3.8.1 Business Overview
      • 15.3.8.2 Products Offered
      • 15.3.8.3 Business Strategies
      • 15.3.8.4 SWOT Analysis
      • 15.3.8.5 Major News and Events

List of Figures

  • Figure 1: Global: Tonometer Market: Major Drivers and Challenges
  • Figure 2: Global: Tonometer Market: Sales Value (in Million USD), 2020-2025
  • Figure 3: Global: Tonometer Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 4: Global: Tonometer Market: Breakup by Type (in %), 2025
  • Figure 5: Global: Tonometer Market: Breakup by Technology (in %), 2025
  • Figure 6: Global: Tonometer Market: Breakup by Portability (in %), 2025
  • Figure 7: Global: Tonometer Market: Breakup by End User (in %), 2025
  • Figure 8: Global: Tonometer Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Tonometer (Direct) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Tonometer (Direct) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Tonometer (Indirect) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Tonometer (Indirect) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Tonometer (Applanation Tonometry) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Tonometer (Applanation Tonometry) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Tonometer (Indentation Tonometry) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Tonometer (Indentation Tonometry) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Tonometer (Rebound Tonometry) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Tonometer (Rebound Tonometry) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Tonometer (Other Technologies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Tonometer (Other Technologies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Tonometer (Desktop) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Tonometer (Desktop) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Tonometer (Handheld) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Tonometer (Handheld) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Tonometer (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Tonometer (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Tonometer (Ophthalmic Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Tonometer (Ophthalmic Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: North America: Tonometer Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: North America: Tonometer Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: United States: Tonometer Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: United States: Tonometer Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Canada: Tonometer Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Canada: Tonometer Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Asia-Pacific: Tonometer Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Asia-Pacific: Tonometer Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: China: Tonometer Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: China: Tonometer Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Japan: Tonometer Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Japan: Tonometer Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: India: Tonometer Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: India: Tonometer Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: South Korea: Tonometer Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: South Korea: Tonometer Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Australia: Tonometer Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Australia: Tonometer Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Indonesia: Tonometer Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Indonesia: Tonometer Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Others: Tonometer Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Others: Tonometer Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Europe: Tonometer Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Europe: Tonometer Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Germany: Tonometer Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Germany: Tonometer Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: France: Tonometer Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: France: Tonometer Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: United Kingdom: Tonometer Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: United Kingdom: Tonometer Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Italy: Tonometer Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Italy: Tonometer Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Spain: Tonometer Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Spain: Tonometer Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Russia: Tonometer Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Russia: Tonometer Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Others: Tonometer Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Others: Tonometer Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Latin America: Tonometer Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Latin America: Tonometer Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Brazil: Tonometer Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Brazil: Tonometer Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Mexico: Tonometer Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Mexico: Tonometer Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Others: Tonometer Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Others: Tonometer Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Middle East and Africa: Tonometer Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Middle East and Africa: Tonometer Market: Breakup by Country (in %), 2025
  • Figure 77: Middle East and Africa: Tonometer Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Global: Tonometer Industry: SWOT Analysis
  • Figure 79: Global: Tonometer Industry: Value Chain Analysis
  • Figure 80: Global: Tonometer Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Tonometer Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Tonometer Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 3: Global: Tonometer Market Forecast: Breakup by Technology (in Million USD), 2026-2034
  • Table 4: Global: Tonometer Market Forecast: Breakup by Portability (in Million USD), 2026-2034
  • Table 5: Global: Tonometer Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 6: Global: Tonometer Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Tonometer Market: Competitive Structure
  • Table 8: Global: Tonometer Market: Key Players